Loss of nuclear BAP1 protein expression is a marker of poor prognosis in patients with clear cell renal cell carcinoma
- 1 August 2016
- journal article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 34 (8) , 338.e11-338.e18
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingNew England Journal of Medicine, 2012
- Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinomaNature Genetics, 2011
- Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinomaNature, 2011
- The Ubiquitin Carboxyl Hydrolase BAP1 Forms a Ternary Complex with YY1 and HCF-1 and Is a Critical Regulator of Gene ExpressionMolecular and Cellular Biology, 2010
- Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genesNature, 2010
- 2009 update on the classification of renal epithelial tumors in adultsInternational Journal of Urology, 2009
- Association of C-Terminal Ubiquitin Hydrolase BRCA1-Associated Protein 1 with Cell Cycle Regulator Host Cell Factor 1Molecular and Cellular Biology, 2009
- BRCA1-Associated Protein-1 Is a Tumor Suppressor that Requires Deubiquitinating Activity and Nuclear LocalizationCancer Research, 2008
- Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in diseaseBriefings in Functional Genomics and Proteomics, 2007
- Prognostic significance of morphologic parameters in renal cell carcinomaAmerican Journal of Surgical Pathology, 1982